Table 1.

Summary of the relationship of each valvular disease with hemodynamic changes and prognosis in patients with concomitant PH at baseline.

Comparison of All Parameters with Patients without Concomitant PH at Baseline
Valvular Disease	Pre-Intervention						Post-Intervention
	LA		LV		Lungs		PASP Reduction	Survival
	LAP	Dimensions	Dimensions	LVFP	PVR	PASP		PH Absence	Transient PH/PASP > 60 mmHg	Persistence PH
MR	↑↑	↑↑	↑↑	↑↑	↑↑	↑↑	√	↓	↓↓	↓↓↓
MS	↑↑↑	↑↑	-	↓	↑↑	↑↑↑	√	-	-	↓
AS	↑↑	↑	-	↑↑	↑	↑	√	↓	↓	↓↓
AR	-	-	↑↑	↑↑	↑↑	↑	√	-	-	↓

MS: Mitral Stenosis, MR: Mitral Regurgitation, AS: Aortic Stenosis, AR: Aortic Regurgitation, LAP: Left Atrium Pressure, PVR: Pulmonary Vascular Resistance, PASP: Pulmonary Arterial Systolic Pressure, LA: Left Atrium, LV: Left Ventricle, PH: Pulmonary Hypertension, LVFP: Left Ventricular Filing Pressure. Number of arrows depict amount of change, ↑: increase, ↓decrease, -: no significant change, √: PASP reduction achieved.